This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Corbus Pharmaceuticals Holdings Inc. (CRBP) shed 9.79% to $9.95 Monday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average rising 0.32% to 49,686.12 and the NASDAQ Composite Index falling 0.51% to 26,090.73.
This was the stock's third consecutive day of losses.
Corbus Pharmaceuticals Holdings Inc. closed 51.61% short of its 52-week high of $20.56, which the company achieved on October 20th.
The stock underperformed when compared to some of its competitors Monday, as Vanda Pharmaceuticals Inc. (VNDA) fell 3.18% to $6.08, Fortress Biotech Inc. (FBIO) rose 2.90% to $2.48, and Viking Therapeutics Inc. (VKTX) fell 5.22% to $28.69.
Trading volume (232,939) remained 30,615 below its 50-day average volume of 263,554.
Data source: Dow Jones Market Data, FactSet. Data compiled May 18, 2026.
This content was created by MarketWatch, which is operated by Dow Jones &amp; Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
05-18-26 1720ET

CRBP

LABU

IBBQ

SBIO

Corbus Pharmaceuticals Holdings Inc. (CRBP) shares fell 9.79% to $9.95 on Monday, marking the third consecutive day of losses. The stock is currently 51.61% below its 52-week high of $20.56. In comparison, competitors had mixed results, with Vanda Pharmaceuticals down 3.18%, Fortress Biotech up 2.90%, and Viking Therapeutics down 5.22%. Trading volume was 232,939, below the 50-day average of 263,554.

MarketWatch Automated

Corbus Pharma

Direxion S&P Biotech Bull 3X

Invesco Nasdaq Biotechnology ETF

VanEck Biotech ETF

iShares Biotechnology ETF

SPDR S&P Biotech

First Trust NYSE Arca Biotech Index Fd

Invesco Biotechnology & Genome ETF

ALPS Medical Breakthrough

Proshares Ultra Nasdaq Biotech

Dow Jones Industrial Average

NASDAQ Composite Index

Vanda Pharma

Fortress Biotech

Viking Therap

Fortress Biotech Pref Share FBIOP 9.375 15/12/22

Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Monday When Compared To Competitors